Open AccessLiver-Selective Glucocorticoid Antagonists: A Novel Treatment for Type 2 Diabetes.
Author(s) -
Thomas W von Geldern,
Noah P. Tu,
Philip R. Kym,
J. T. Link,
Hwan-Soo Jae,
Chunqiu Lai,
T. Apelqvist,
P. Rhönnstad,
Lars Hagberg,
Konrad F. Koehler,
Marlena Grynfarb,
Annika GoosNilsson,
Johnny Sandberg,
Marie K. Österlund,
Tomas Barkhem,
Marie Höglund,
Jiahong Wang,
Steven Fung,
Denise Wilcox,
Phong Nguyen,
Clarissa G. Jakob,
Charles W. Hutchins,
Mathias Färnegårdh,
Björn Kauppi,
Lars Öhman,
Peer B. Jacobson
Publication year - 2005
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/jm058170f
Subject(s) - chemistry , glucocorticoid , type 2 diabetes , pharmacology , diabetes mellitus , endocrinology , medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom